AHF favors cheaper Hepatitis C treatment

The AIDS Healthcare Foundation (AHF) praised a decision by Express Scripts Holding Co. on Monday to drop a higher priced Hepatitis C treatment in favor of AbbVie Inc.’s cheaper Viekira Pak treatment option.

“The decision by Express Scripts to choose the Viekira Pak over Sovaldi demonstrates the limits of big pharma’s greed and arrogance,” Michael Weinstein, president of AHF, said. “Gilead wrongly believed they could get away with charging through the roof for Sovaldi and now their strategy has clearly backfired. With private insurers and taxpayers footing the bill for most of these life-saving treatments, it is now incumbent that the government and other companies follow suit in standing up to these attempts at public extortion.”

“AbbVie’s price is only slightly less outrageous but it might serve as a warning to other companies that market competition combined with public revulsion can restrain prices even when the government refuses to act,” Weinstein said.

Read more...

Labels: , ,